Cronos Valuation

CRON Stock  USD 2.13  0.05  2.40%   
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Cronos Group shows a prevailing Real Value of $2.72 per share. The current price of the firm is $2.13. Our model approximates the value of Cronos Group from analyzing the firm fundamentals such as Return On Equity of -0.0529, current valuation of (67.21 M), and Profit Margin of (0.56) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cronos' valuation include:
Price Book
0.7352
Enterprise Value
-67.2 M
Enterprise Value Ebitda
(1.42)
Price Sales
7.8131
Enterprise Value Revenue
0.0188
Undervalued
Today
2.13
Please note that Cronos' price fluctuation is unstable at this time. Calculation of the real value of Cronos Group is based on 3 months time horizon. Increasing Cronos' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cronos is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cronos Stock. However, Cronos' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.13 Real  2.72 Target  3.66 Hype  2.13 Naive  2.15
The intrinsic value of Cronos' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cronos' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.72
Real Value
5.87
Upside
Estimating the potential upside or downside of Cronos Group helps investors to forecast how Cronos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cronos more accurately as focusing exclusively on Cronos' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.08-0.07-0.07
Details
Hype
Prediction
LowEstimatedHigh
0.112.135.28
Details
Naive
Forecast
LowNext ValueHigh
0.042.155.30
Details
6 Analysts
Consensus
LowTarget PriceHigh
3.333.664.06
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cronos' intrinsic value based on its ongoing forecasts of Cronos' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cronos' closest peers.

Cronos Cash

463.4 Million

Cronos Valuation Trend

Knowing Cronos' actual value is paramount for traders when making sound investment determinations. Using both Cronos' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

Cronos Revenue by Product

Cronos Total Value Analysis

Cronos Group is currently estimated to have valuation of (67.21 M) with market capitalization of 795.17 M, debt of 2.55 M, and cash on hands of 944.89 M. The negative valuation of Cronos may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Cronos fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(67.21 M)
795.17 M
2.55 M
944.89 M

Cronos Investor Information

About 46.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.74. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cronos Group recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. Based on the key indicators related to Cronos' liquidity, profitability, solvency, and operating efficiency, Cronos Group may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.

Cronos Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cronos has an asset utilization ratio of 7.83 percent. This suggests that the Company is making $0.0783 for each dollar of assets. An increasing asset utilization means that Cronos Group is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid

Cronos Ownership Allocation

Cronos holds a total of 382.3 Million outstanding shares. Cronos Group retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Cronos Profitability Analysis

The company reported the previous year's revenue of 88.84 M. Net Loss for the year was (71.13 M) with profit before overhead, payroll, taxes, and interest of 11.97 M.

About Cronos Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cronos Group. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cronos Group based exclusively on its fundamental and basic technical indicators. By analyzing Cronos's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cronos's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cronos. We calculate exposure to Cronos's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cronos's related companies.
Last ReportedProjected for Next Year
Gross ProfitM7.3 M
Pretax Profit Margin(0.84)(0.80)
Operating Profit Margin(0.97)(1.02)
Net Loss(0.85)(0.81)
Gross Profit Margin 0.14  0.13 

Cronos Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding381 M
Quarterly Earnings Growth Y O Y0.144

Cronos Current Valuation Indicators

Cronos' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cronos' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cronos, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cronos' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cronos' worth.
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.144
Earnings Share
(0.12)
Revenue Per Share
0.267
Quarterly Revenue Growth
0.46
Return On Assets
(0.04)
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.